India’s food regulator has stepped in amid growing scrutiny around the safety claims of Eggoz, a Bengaluru based egg startup. The Food Safety and Standards Authority of India has directed its regional offices to collect samples of both branded and unbranded eggs from across the country following concerns around the possible presence of carcinogenic substances.
According to sources cited by news agency ANI, the collected samples will be tested at ten laboratories nationwide. The primary focus of the testing will be on nitrofurans, a class of antibiotics that are banned for use in food producing animals due to their potential cancer causing properties. The move comes after social media chatter and consumer reports triggered questions about egg safety standards and sourcing practices in the poultry sector.
Eggoz, which positions itself as a premium and traceable egg brand, has strongly denied the allegations. Over the weekend, the company released test reports from a NABL accredited laboratory stating that carcinogenic compounds in its eggs were below the limit of quantification. The startup added that the testing covered a wide range of parameters including microbiological safety, chemical composition, heavy metals, antibiotic residues, pesticides, natural toxins and other contaminants.
The company has maintained that its products are safe for consumption and compliant with Indian food safety norms. Industry observers note that while regulatory testing is routine, public scrutiny has intensified as food startups scale rapidly and market transparency becomes a key differentiator.
The FSSAI’s findings are now awaited closely, not just by Eggoz but by the broader poultry and foodtech ecosystem. The outcome could influence future testing protocols, consumer trust, and how food brands communicate safety claims in an increasingly aware market.
